Is this the time to reimagine pharma selling in government institutions? More importantly, with govt seemingly discouraging pharma-HCP contact, is this a cue to reimagine pharma selling at large?
Agreed but there is one more aspect in this, where MR has some connect with the doctors they tend to detail in parking lots, outside eatery outlets (Mess) etc.
This I have seen in CIP Ranchi where MR visit is banned post COVID. Usually HCP's stand and listen to field when they detail.
Agreed but there is one more aspect in this, where MR has some connect with the doctors they tend to detail in parking lots, outside eatery outlets (Mess) etc.
This I have seen in CIP Ranchi where MR visit is banned post COVID. Usually HCP's stand and listen to field when they detail.